SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-054479
Filing Date
2021-04-23
Accepted
2021-04-23 16:30:39
Documents
6
Period of Report
2021-06-03

Document Format Files

Seq Description Document Type Size
1 DEF 14A tm212641-1_def14a.htm DEF 14A 1147128
2 GRAPHIC lg_caratmtherap-4c.jpg GRAPHIC 39308
3 GRAPHIC sg_derekchalmers-bw.jpg GRAPHIC 8622
4 GRAPHIC sg_scottmterrillion-bw.jpg GRAPHIC 6613
5 GRAPHIC tm212641d1-pc_01proxybw.jpg GRAPHIC 877678
6 GRAPHIC tm212641d1-pc_02proxybw.jpg GRAPHIC 646423
  Complete submission text file 0001104659-21-054479.txt   3319015
Mailing Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902
Business Address 4 STAMFORD PLAZA 107 ELM STREET 9TH FLOOR STAMFORD CT 06902 203-406-3700
Cara Therapeutics, Inc. (Filer) CIK: 0001346830 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36279 | Film No.: 21850217
SIC: 2834 Pharmaceutical Preparations